Stricter Vaccine Approval Rules Coming From FDA

If approved by the White House, revised guidelines could be released as early as next week

WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Stricter guidelines for emergency authorization use of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.

The guidelines would outline more specific criteria for clinical trial data and recommend the data be reviewed by a committee of independent experts before the FDA authorizes any vaccine, people familiar with the draft told The New York Times.

If approved by the White House, the revised guidelines could be released as early as next week.

The move to tighten the rules on emergency vaccine approval come as President Donald Trump keeps promising that a vaccine will be available as early as next month, The Times reported.

The New York Times Article

U.S. Burden of Skin and Subcutaneous Diseases Increasing

Can dermatology employers require employees to receive the COVID-19 vaccine?

THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

Expression of retinoid receptors in hand eczema.

S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

Stricter Vaccine Approval Rules Coming From FDA

If approved by the White House, revised guidelines could be released as early as next week